Real-time enrollment status for this alzheimer disease clinical trial
Current Status
Recruiting
Checked: October 8, 2026 at 9:39 PM UTC
| NCT Number | NCT07787169 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer Disease |
| Phase | PHASE1 |
| Target Enrollment | 179 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | October 8, 2026 (21 hours ago) |
As of October 8, 2026: Clinical trial NCT07787169 is currently recruiting participants. This phase1 study for alzheimer disease is actively seeking new participants at 13 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07787169 is actively recruiting participants as of October 8, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07787169 was last updated 21 hours ago (October 8, 2026). HelloStudys verifies this status automatically.